Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

Hospital Corporation of China Limited (3869.HK)

Compare
6.800
0.000
(0.00%)
At close: February 7 at 1:45:12 PM GMT+8
Loading Chart for 3869.HK
  • Previous Close 6.800
  • Open 7.240
  • Bid --
  • Ask 6.800 x --
  • Day's Range 7.240 - 7.240
  • 52 Week Range 3.800 - 7.240
  • Volume 1,600
  • Avg. Volume 70
  • Market Cap (intraday) 928.173M
  • Beta (5Y Monthly) -0.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.300
  • Earnings Date Mar 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hospital Corporation of China Limited, an investment holding company, operates and manages hospitals in the People's Republic of China. The company operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products. The company provides inpatient and outpatient, management, supply chain, and other ancillary services to certain hospitals; and property management services. It engages in the wholesale of pharmaceutical products and medical consumables. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited is a subsidiary of Vanguard Glory Limited.

www.hcclhealthcare.com

1,841

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 3869.HK

View More

Performance Overview: 3869.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

3869.HK
0.15%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

3869.HK
6.25%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

3869.HK
22.73%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

3869.HK
41.38%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 3869.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3869.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    928.18M

  • Enterprise Value

    1.29B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    2.57

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    6.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.68%

  • Return on Assets (ttm)

    4.43%

  • Return on Equity (ttm)

    2.36%

  • Revenue (ttm)

    1.44B

  • Net Income Avi to Common (ttm)

    -38.63M

  • Diluted EPS (ttm)

    -0.300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    813.08M

  • Total Debt/Equity (mrq)

    200.15%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 3869.HK

View More

Company Insights: 3869.HK

Research Reports: 3869.HK

View More

People Also Watch